Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 747645, 20 pages
http://dx.doi.org/10.1155/2015/747645
Research Article

IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation

1Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy
2Department of Human Pathology, University of Palermo, 90127 Palermo, Italy
3Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Microbiology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy
4Department of Clinical and Experimental Medicine, Medical School of Novara, 28100 Novara, Italy
5Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Otolaryngology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy
6Department of Public Health and Microbiology, University of Turin, 10126 Turin, Italy
7Department of Pathology and Diagnostic, University of Verona, 35124 Verona, Italy

Received 6 February 2015; Revised 27 April 2015; Accepted 14 May 2015

Academic Editor: Douglas C. Hooper

Copyright © 2015 Pier Paolo Piccaluga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Akashi, M. Kondo, S. Cheshier et al., “Lymphoid development from stem cells and the common lymphocyte progenitors,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 64, pp. 1–12, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Berek, A. Berger, and M. Apel, “Maturation of the immune response in germinal centers,” Cell, vol. 67, no. 6, pp. 1121–1129, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. I. C. M. MacLennan, “Germinal centers,” Annual Review of Immunology, vol. 12, pp. 117–139, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Klein and R. Dalla-Favera, “Germinal centres: role in B-cell physiology and malignancy,” Nature Reviews Immunology, vol. 8, no. 1, pp. 22–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Dent, A. L. Shaffer, X. Yu, D. Allman, and L. M. Staudt, “Control of inflammation, cytokine expression, and germinal center formation by BCL-6,” Science, vol. 276, no. 5312, pp. 589–592, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-W. Mittrücker, T. Matsuyama, A. T. Grossman et al., “Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function,” Science, vol. 275, no. 5299, pp. 540–543, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. B. H. Ye, G. Cattoretti, Q. Shen et al., “The BCL-6 proto-oncogene controls germinal-centre formation and Th2- type inflammation,” Nature Genetics, vol. 16, no. 2, pp. 161–170, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Shapiro-Shelef, K.-I. Lin, L. J. McHeyzer-Williams, J. Liao, M. G. McHeyzer-Williams, and K. Calame, “Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells,” Immunity, vol. 19, no. 4, pp. 607–620, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Scheeren, M. Naspetti, S. Diehl et al., “STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression,” Nature Immunology, vol. 6, no. 3, pp. 303–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. C. H. Lee, M. Melchers, H. Wang et al., “Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein,” The Journal of Experimental Medicine, vol. 203, no. 1, pp. 63–72, 2006. View at Publisher · View at Google Scholar
  11. J. L. Fornek, L. T. Tygrett, T. J. Waldschmidt, V. Poli, R. C. Rickert, and G. S. Kansas, “Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells,” Blood, vol. 107, no. 3, pp. 1085–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Cobaleda, A. Schebesta, A. Delogu, and M. Busslinger, “Pax5: the guardian of B cell identity and function,” Nature Immunology, vol. 8, no. 5, pp. 463–470, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Veeranki and D. Choubey, “Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins,” Immunology Letters, vol. 133, no. 1, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. E. A. Ludlow, R. W. Johnstone, and C. J. P. Clarke, “The HIN-200 family: more than interferon-inducible genes?” Experimental Cell Research, vol. 308, no. 1, pp. 1–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Gariglio, M. Mondini, M. de Andrea, and S. Landolfo, “The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology,” Journal of Interferon and Cytokine Research, vol. 31, no. 1, pp. 159–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. Johnstone, M. H. Kershaw, and J. A. Trapani, “Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing,” Biochemistry, vol. 37, no. 34, pp. 11924–11931, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. M. J. Dawson, N. J. Elwood, R. W. Johnstone, and J. A. Trapani, “The IFN-inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down-regulated in other myeloid precursor populations,” Journal of Leukocyte Biology, vol. 64, no. 4, pp. 546–554, 1998. View at Google Scholar · View at Scopus
  18. M. Gariglio, B. Azzimonti, M. Pagano et al., “Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells,” Journal of Interferon and Cytokine Research, vol. 22, no. 7, pp. 815–821, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Wei, C. J. P. Clarke, G. R. Somers et al., “Expression of IFI16 in epithelial cells and lymphoid tissues,” Histochemistry and Cell Biology, vol. 119, no. 1, pp. 45–54, 2003. View at Google Scholar · View at Scopus
  20. H. Xin, J. Curry, R. W. Johnstone, B. J. Nickoloff, and D. Choubey, “Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence,” Oncogene, vol. 22, no. 31, pp. 4831–4840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Raffaella, D. Gioia, M. de Andrea et al., “The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells,” Experimental Cell Research, vol. 293, no. 2, pp. 331–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. E.-J. Kim, J.-I. Park, and B. D. Nelkin, “IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4913–4920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Choubey, R. Deka, and S.-M. Ho, “Interferon-inducible IFI16 protein in human cancers and autoimmune diseases,” Frontiers in Bioscience, vol. 13, no. 2, pp. 598–608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. L. L. Song, F. Alimirah, R. Panchanathan, H. Xin, and D. Choubey, “Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53,” Molecular Cancer Research, vol. 6, no. 11, pp. 1732–1741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Asefa, K. D. Klarmann, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and J. R. Keller, “The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation,” Blood Cells, Molecules, and Diseases, vol. 32, no. 1, pp. 155–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. P. Clarke, L. L. Hii, J. E. Bolden, and R. W. Johnstone, “Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence,” Journal of Cellular Biochemistry, vol. 109, no. 1, pp. 103–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. L. Song, L. Ponomareva, H. Shen, X. Duan, F. Alimirah, and D. Choubey, “Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene,” PLoS ONE, vol. 5, no. 1, Article ID e8569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. C. Kwak, P. P. Ongusaha, T. Ouchi, and S. W. Lee, “IFI16 as a negative regulator in the regulation of p53 and p21Waf1,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 40899–40904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Ouchi and T. Ouchi, “Role of IFI16 in DNA damage and checkpoint,” Frontiers in Bioscience, vol. 13, no. 1, pp. 236–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Fujiuchi, J. A. Aglipay, T. Ohtsuka et al., “Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation,” The Journal of Biological Chemistry, vol. 279, no. 19, pp. 20339–20344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Alimirah, J. Chen, F. J. Davis, and D. Choubey, “IFI16 in human prostate cancer,” Molecular Cancer Research, vol. 5, no. 3, pp. 251–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Gugliesi, M. de Andrea, M. Mondini et al., “The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity,” Journal of Autoimmunity, vol. 35, no. 2, pp. 114–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Wagner, A. Ansorge, U. Wirkner et al., “Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis,” Blood, vol. 104, no. 3, pp. 675–686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Gibellini, F. Alviano, A. Miserocchi et al., “HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells,” Retrovirology, vol. 8, article 40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Mondini, S. Costa, S. Sponza, F. Gugliesi, M. Gariglio, and S. Landolfo, “The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity,” Autoimmunity, vol. 43, no. 3, pp. 226–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Gugliesi, M. Mondini, R. Ravera et al., “Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 820–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. W. Johnstone and J. A. Trapani, “Transcription and growth regulatory functions of the HIN-200 family of proteins,” Molecular and Cellular Biology, vol. 19, no. 9, pp. 5833–5838, 1999. View at Google Scholar · View at Scopus
  39. L. Unterholzner, S. E. Keating, M. Baran et al., “IFI16 is an innate immune sensor for intracellular DNA,” Nature Immunology, vol. 11, no. 11, pp. 997–1004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Paludan, A. G. Bowie, K. A. Horan, and K. A. Fitzgerald, “Recognition of herpesviruses by the innate immune system,” Nature Reviews Immunology, vol. 11, no. 2, pp. 143–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. J. Dawson and J. A. Trapani, “IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines,” Journal of Cellular Biochemistry, vol. 57, no. 1, pp. 39–51, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. R. S. Robetorye, S. D. Bohling, J. W. Morgan, G. C. Fillmore, M. S. Lim, and K. S. J. Elenitoba-Johnson, “Microarray analysis of B-cell lymphoma cell lines with the t(14;18),” Journal of Molecular Diagnostics, vol. 4, no. 3, pp. 123–136, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. J. D. Shaughnessy Jr., F. Zhan, B. E. Burington et al., “Avalidated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1,” Blood, vol. 109, no. 6, pp. 2276–2284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. P. P. Piccaluga, A. Califano, U. Klein et al., “Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas,” Haematologica, vol. 93, no. 7, pp. 1033–1038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. P. P. Piccaluga, G. De Falco, M. Kustagi et al., “Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes,” Blood, vol. 117, no. 13, pp. 3596–3608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. P. P. Piccaluga, C. Agostinelli, A. Califano et al., “Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 823–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Basso, U. Klein, H. Niu et al., “Tracking CD40 signaling during germinal center development,” Blood, vol. 104, no. 13, pp. 4088–4096, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Basso, A. A. Margolin, G. A. Stolovitzky, U. Klein, R. Dalla-Favera, and A. Califano, “Reverse engineering of regulatory networks in human B cells,” Nature Genetics, vol. 37, no. 4, pp. 382–390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. A. A. Margolin, I. Nemenman, K. Basso et al., “ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context,” BMC Bioinformatics, vol. 7, supplement 1, article S7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. A. A. Margolin, K. Wang, W. K. Lim, M. Kustagi, I. Nemenman, and A. Califano, “Reverse engineering cellular networks,” Nature Protocols, vol. 1, no. 2, pp. 662–671, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Basso, M. Saito, P. Sumazin et al., “Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells,” Blood, vol. 115, no. 5, pp. 975–984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Eric Davis, K. D. Brown, U. Siebenlist, and L. M. Staudt, “Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1861–1874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Wu, S. Chesoni, G. Rondeau et al., “Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs,” Nucleic Acids Research, vol. 41, no. 4, pp. 2644–2658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. M. K. Kjeldsen, M. Perez-Andres, A. Schmitz et al., “Multiparametric flow cytometry for identification and fluorescence activated cell sorting of five distinct B-cell subpopulations in normal tonsil tissue,” American Journal of Clinical Pathology, vol. 136, no. 6, pp. 960–969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Y. Mason, K. Micklem, and M. Jones, “Double immunofluorescence labelling of routinely processed paraffin sections,” The Journal of Pathology, vol. 191, no. 4, pp. 452–461, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Wessa, “Pearson Correlation (v1.0.3) in Free Statistics Software (v1.1.23-r6), Office for Research Development and Education,” 2008, http://www.wessa.net/rwasp_correlation.wasp/.
  57. B. J. Barnes, J. Richards, M. Mancl, S. Hanash, L. Beretta, and P. M. Pitha, “Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection,” Journal of Biological Chemistry, vol. 279, no. 43, pp. 45194–45207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Caposio, F. Gugliesi, C. Zannetti et al., “A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells,” The Journal of Biological Chemistry, vol. 282, no. 46, pp. 33515–33529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Sponza, M. de Andrea, M. Mondini, F. Gugliesi, M. Gariglio, and S. Landolfo, “Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-α,” Cellular Immunology, vol. 257, no. 1-2, pp. 55–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. L. M. Staudt, “Oncogenic activation of NF-κB,” Cold Spring Harbor perspectives in biology, vol. 2, no. 6, Article ID a000109, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. A. N. Shakhov, M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel, “κ B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages,” Journal of Experimental Medicine, vol. 171, no. 1, pp. 35–47, 1990. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Schwenzer, K. Siemienski, S. Liptay et al., “The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase,” The Journal of Biological Chemistry, vol. 274, no. 27, pp. 19368–19374, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Van de Stolpe, E. Caldenhoven, B. G. Stade et al., “12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecule-1 promoter,” Journal of Biological Chemistry, vol. 269, no. 8, pp. 6185–6192, 1994. View at Google Scholar · View at Scopus
  65. A. L. Shaffer, X. Yu, Y. He, J. Boldrick, E. P. Chan, and L. M. Staudt, “BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control,” Immunity, vol. 13, no. 2, pp. 199–212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Pasqualucci, O. Bereschenko, H. Niu et al., “Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6,” Leukemia & Lymphoma, vol. 44, supplement 3, pp. S5–S12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Fujita, D. L. Jaye, C. Geigerman et al., “MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation,” Cell, vol. 119, no. 1, pp. 75–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Parekh, J. M. Polo, R. Shaknovich et al., “BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms,” Blood, vol. 110, no. 6, pp. 2067–2074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. S. M. Ranuncolo, L. Wang, J. M. Polo et al., “BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner,” The Journal of Biological Chemistry, vol. 283, no. 33, pp. 22565–22572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Basso and R. Dalla-Favera, “BCL6. master regulator of the germinal center reaction and key oncogene in B Cell lymphomagenesis,” Advances in Immunology, vol. 105, pp. 193–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. R. T. Phan and R. Dalla-Favera, “The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B-cells,” Nature, vol. 432, no. 7017, pp. 635–639, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. R. W. Johnstone, W. Wei, A. Greenway, and J. A. Trapani, “Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16,” Oncogene, vol. 19, no. 52, pp. 6033–6042, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. J. A. Aglipay, S. W. Lee, S. Okada et al., “A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway,” Oncogene, vol. 22, no. 55, pp. 8931–8938, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. J. C. C. Liao, R. Lam, V. Brazda et al., “Interferon-inducible protein 16: Insight into the interaction with tumor suppressor p53,” Structure, vol. 19, no. 3, pp. 418–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Goubau, J. Rehwinkel, and C. R. E. Sousa, “PYHIN proteins: center stage in DNA sensing,” Nature Immunology, vol. 11, no. 11, pp. 984–986, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Chadwick, C. Fennessy, M. C. Nostro, M. Baron, G. Brady, and A.-M. Buckle, “Notch induces cell cycle arrest and apoptosis in human erythroleukaemic TF-1 cells,” Blood Cells, Molecules, and Diseases, vol. 41, no. 3, pp. 270–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Mazibrada, M. de Andrea, M. Rittà et al., “In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16,” Cancer Letters, vol. 287, no. 1, pp. 33–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. M. H. Kosco-Vilbois, J. Y. Bonnefoy, and Y. Chvatchko, “The physiology of murine germinal center reactions,” Immunological Reviews, vol. 156, pp. 127–136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  79. G. H. Su, H.-M. Chen, N. Muthusamy et al., “Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B,” The EMBO Journal, vol. 16, no. 23, pp. 7118–7129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Muto, S. Tashiro, O. Nakajima et al., “The transcriptional programme of antibody class switching involves the repressor Bach2,” Nature, vol. 429, no. 6991, pp. 566–571, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. R. W. E. Clarkson, M. P. Boland, E. A. Kritikou et al., “The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development,” Molecular Endocrinology, vol. 20, no. 3, pp. 675–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. E.-J. Kim, J.-I. Park, and B. D. Nelkin, “IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells,” Journal of Biological Chemistry, vol. 280, no. 6, pp. 4913–4920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. U. Klein and R. Dalla-Favera, “Unexpected steps in plasma-cell differentiation,” Immunity, vol. 26, no. 5, pp. 543–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. C. A. Turner Jr., D. H. Mack, and M. M. Davis, “Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells,” Cell, vol. 77, no. 2, pp. 297–306, 1994. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Gerondakis, R. Grumont, I. Rourke, and M. Grossmann, “The regulation and roles of Rel/NF-kappaB transcription factors during lymphocyte activation,” Current Opinion in Immunology, vol. 10, no. 3, pp. 353–359, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Berry, L. Matthews, M. Jangani et al., “Interferon-inducible factor 16 is a novel modulator of glucocorticoid action,” The FASEB Journal, vol. 24, no. 6, pp. 1700–1713, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Kondo, K. Nagai, S. Nakahata et al., “Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation,” Cancer Science, vol. 103, no. 4, pp. 782–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. M. R. Jakobsen and S. R. Paludan, “IFI16: at the interphase between innate DNA sensing and genome regulation,” Cytokine & Growth Factor Reviews, vol. 25, no. 6, pp. 649–655, 2014. View at Publisher · View at Google Scholar
  89. M. R. Jakobsen, R. O. Bak, A. Andersen et al., “IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 48, pp. E4571–E4580, 2013. View at Publisher · View at Google Scholar · View at Scopus